Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.5M Buy
1,132,130
+529,237
+88% +$16M 0.01% 1050
2026
Q1
$16.8M Buy
602,893
+498,659
+478% +$12.7M 0.01% 1263
2025
Q4
$2.04M Buy
+104,234
New +$2.2M ﹤0.01% 3032
2024
Q3
Sell
-197,324
Closed -$7.65M 4901
2024
Q2
$7.65M Buy
+197,324
New +$7.07M 0.01% 1522
2023
Q1
Sell
-7,988
Closed -$243K 4867
2022
Q4
$233K Sell
7,988
-89,086
-92% -$2.4M ﹤0.01% 4183
2022
Q3
$1.97M Sell
97,074
-50,980
-34% -$917K ﹤0.01% 3029
2022
Q2
$2.01M Buy
+148,054
New +$1.74M ﹤0.01% 3075

Other funds holding TRMD

David Shaw's TRMD Position: Q2 2026 in Review

David Shaw increased its TORM (TRMD) stake by 88% in Q2 2026, buying an estimated $16M and bringing the position to 1,132,130 shares worth $29.5M. The position accounts for 0.01% of the portfolio, ranked #1050.

David Shaw first reported a position in TRMD in Q2 2022 and has held it in 7 quarters since. 151 funds tracked by Wall St. Rank hold TRMD as of Q2 2026.

  • David Shaw held 1,132,130 shares of TORM worth $29.5M as of Q2 2026.
  • David Shaw bought 529,237 TORM shares in Q2 2026, an estimated $16M.
  • TORM made up 0.01% of David Shaw's portfolio in Q2 2026, its #1050 holding.
  • David Shaw first reported a position in TORM in Q2 2022 and has held it in 7 quarters since.
  • 151 funds tracked by Wall St. Rank held TORM as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.